2 unknown. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Unknown 2 |
Follow Systemic Vasculitis: new trials by email Literature Review of Systemic Vasculitis trials Research Report on Systemic Vasculitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases CD19-CAR-DNT cells - Systemic Lupus Erythematosus, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis | Phase 1 | Unknown | RenJi Hospital | 48 | 2023-10-30 | 2024-03-18 |
| Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease CD19 targeted CAR-T cells - SLE (Systemic Lupus), Sjogren's Syndrome | Phase 1 | Unknown | Chongqing Precision Biotech Co., Ltd | 24 | 2023-08-31 | 2023-09-28 |
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (2) · Lupus Erythematosus, Systemic (2) · Scleroderma, Systemic (2) · Dermatomyositis (1) · Myositis (1) · Sjogren's Syndrome (1)
Autoimmune Diseases (2) · Cardiovascular Diseases (2) · Connective Tissue Diseases (2) · Immune System Diseases (2) · Muscular Diseases (2) · Musculoskeletal Diseases (2) · Nervous System Diseases (2) · Neuromuscular Diseases (2) · Skin Diseases (2) · Skin Diseases, Vascular (2) · Skin and Connective Tissue Diseases (2) · Vascular Diseases (2) · Vasculitis (2) · Arthritis (1)
Cyclophosphamide (1) · fludarabine (1)
Chongqing Precision Biotech Co., Ltd (1) · RenJi Hospital (1)
China (2)
Liyun Zhang, M.D (1)